<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pereira GV</submitter><funding>NIDDK NIH HHS</funding><funding>Horizon 2020 Marie Skłodowska-Curie Actions</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NHLBI NIH HHS</funding><funding>FNR</funding><funding>National Heart Lung and Blood Institute</funding><funding>Fulbright Association</funding><funding>NIGMS NIH HHS</funding><funding>Kenneth Rainin foundation</funding><pagination>527-542.e9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11064055</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(4)</volume><pubmed_abstract>Inflammatory bowel diseases (IBDs) are chronic conditions characterized by periods of spontaneous intestinal inflammation and are increasing in industrialized populations. Combined with host genetics, diet and gut bacteria are thought to contribute prominently to IBDs, but mechanisms are still emerging. In mice lacking the IBD-associated cytokine, interleukin-10, we show that a fiber-deprived gut microbiota promotes the deterioration of colonic mucus, leading to lethal colitis. Inflammation starts with the expansion of natural killer cells and altered immunoglobulin-A coating of some bacteria. Lethal colitis is then driven by Th1 immune responses to increased activities of mucin-degrading bacteria that cause inflammation first in regions with thinner mucus. A fiber-free exclusive enteral n</pubmed_abstract><journal>Cell host &amp; microbe</journal><pubmed_title>Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host.</pubmed_title><pmcid>PMC11064055</pmcid><funding_grant_id>P01 HL149633</funding_grant_id><funding_grant_id>T32 GM007544</funding_grant_id><funding_grant_id>R01 DK125445</funding_grant_id><funding_grant_id>R01 DK118024</funding_grant_id><pubmed_authors>Desai MS</pubmed_authors><pubmed_authors>Shan M</pubmed_authors><pubmed_authors>Kim K</pubmed_authors><pubmed_authors>Fuentes J</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Willieme S</pubmed_authors><pubmed_authors>Grant ET</pubmed_authors><pubmed_authors>Pereira GV</pubmed_authors><pubmed_authors>Pudlo NA</pubmed_authors><pubmed_authors>Eaton KA</pubmed_authors><pubmed_authors>Denike-Duval T</pubmed_authors><pubmed_authors>Boudaud M</pubmed_authors><pubmed_authors>Alexander C</pubmed_authors><pubmed_authors>Singh S</pubmed_authors><pubmed_authors>Schmidt TM</pubmed_authors><pubmed_authors>Chen GY</pubmed_authors><pubmed_authors>Kennedy L</pubmed_authors><pubmed_authors>Bleich A</pubmed_authors><pubmed_authors>Wolter M</pubmed_authors><pubmed_authors>Martens EC</pubmed_authors><pubmed_authors>Trindade BC</pubmed_authors><pubmed_authors>Campbell A</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>De Sciscio A</pubmed_authors><pubmed_authors>Lyssiotis CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host.</name><description>Inflammatory bowel diseases (IBDs) are chronic conditions characterized by periods of spontaneous intestinal inflammation and are increasing in industrialized populations. Combined with host genetics, diet and gut bacteria are thought to contribute prominently to IBDs, but mechanisms are still emerging. In mice lacking the IBD-associated cytokine, interleukin-10, we show that a fiber-deprived gut microbiota promotes the deterioration of colonic mucus, leading to lethal colitis. Inflammation starts with the expansion of natural killer cells and altered immunoglobulin-A coating of some bacteria. Lethal colitis is then driven by Th1 immune responses to increased activities of mucin-degrading bacteria that cause inflammation first in regions with thinner mucus. A fiber-free exclusive enteral n</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-06-03T01:19:20.96Z</modification><creation>2025-07-13T03:05:11.33Z</creation></dates><accession>S-EPMC11064055</accession><cross_references><pubmed>38513656</pubmed><doi>10.1016/j.chom.2024.03.001</doi></cross_references></HashMap>